Skip to main content
OpenTrials
Completed

NCT Number: NCT02924571

BMAC & Allograft vs BMP-2

The aim of this investigation is to compare the use of bone marrow aspirate concentrate (BMAC) and allograft versus recombinant human bone morphogenetic protein-2 (BMP) versus the gold standard fusion in subjects undergoing elective lumbar spinal fusion with interbody support. The safety and efficacy of the surgical interventions will be evaluated by assessing fusion status and subjects' quality of life outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Spinal Fusion

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

New York University School of Medicine

New York, 10016, United States

About this study

This study will be a prospective, randomized clinical study at a single-center, NYU Langone Medical Center. It is intended to compare and evaluate the efficacy of subjects who are either treated with (1) bone marrow aspirate concentrate (BMAC) and allograft or (2) recombinant human bone morphogenetic protein-2 (BMP) or (3) autograft (control) during lumbar spinal fusion with interbody support. The clinical, radiographic, and Health Related Quality of Life (HRQOL) outcomes will be assessed in operatively treated adult spinal degenerative disease patients undergoing lumbar spinal fusion.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Must be 18 years old or older
  • Scheduled for elective posterior or anterior and posterior spinal fusion of the thoracolumbar spine with or without anterior interbody support
  • Failed at least 6 weeks of conservative care
  • No contraindication to BMAC (as per manufacturer)
  • Signed consent form

Exclusion criteria

  • Prior lumbar fusion surgery at operative level (prior discectomy and/or laminectomy allowed)
  • Incompetent or missing anterior arch at the affected level (e.g. laminectomy, pars defect)
  • Currently requires laminectomy at level of surgery
  • Facet joints at implant level are absent or fractured
  • Post-traumatic vertebral body compromise or acute fracture at implant level
  • Body mass Index (BMI) > 40
  • Known allergy to titanium
  • Paget's disease, osteomalacia, or any other metabolic bone disease
  • Use of medications or any drug known to potentially interfere with bone/soft tissue healing (e.g. chronic systemic steroids)
  • Unlikely to comply with the follow-up evaluation schedule
  • Active malignancy defined as history of invasive malignancy, except if the subject has received treatment and displayed no clinical signs and symptoms for at least five years
  • Pregnant or planning to become pregnant during the length of study participation

Treatment and study plan

Bone Marrow Aspirate Concentrate (BMAC) + Allograft

Device

Allograft infused with adult stem cells from the bone marrow aspirate harvested from the iliac crest. Harvest BMAC System delivers high stem cell concentration to the graft site.

Other names: Harvest BMAC System

Recombinant Human Bone Morphogenetic Protein-2 (BMP)

Device

INFUSE rhBMP-2 Bone Graft used according to its approved FDA labels, both from an anterior approach using titanium cages as well as from a posterior interbody approach using polyetheretherketone (PEEK) cages.

Other names: INFUSE rhBMP-2

Autograft

Procedure

Autograft with bone marrow aspirate.

Primary outcomes

  1. Number of Participants With Successful Fusion Status at Month 12 Post-Procedure

    Time frame: Month 12 Post-Operation

    Fusion status assessed via CT scan by an independent radiologist.

  2. Oswestry Disability Index (ODI) Score at Pre-Op Visit

    Time frame: Pre-Operation Visit (Day 0)

    The ODI is a questionnaire used to assess the functional disability caused by low back pain. It consists of 10 questions, each rated on a scale of 0 (none) to 5 (extreme). The scores from the 10 questions are added up to obtain the raw score; the raw score is divided by the maximum possible score (50) and multiplied by 100 to obtain a percentage score, interpreted as follows: 0-20%: Minimal disability, 21-40%: Moderate disability, 41-60%: Severe disability, 61-80%: Crippling disability, and 81-100%: Bedridden or completely disabled.

  3. ODI Score at Week 6 Follow-Up

    Time frame: Week 6 Post-Operation

    The ODI is a questionnaire used to assess the functional disability caused by low back pain. It consists of 10 questions, each rated on a scale of 0 (none) to 5 (extreme). The scores from the 10 questions are added up to obtain the raw score; the raw score is divided by the maximum possible score (50) and multiplied by 100 to obtain a percentage score, interpreted as follows: 0-20%: Minimal disability, 21-40%: Moderate disability, 41-60%: Severe disability, 61-80%: Crippling disability, and 81-100%: Bedridden or completely disabled.

  4. ODI Score at Month 3 Follow-Up

    Time frame: Month 3 Post-Operation

    The ODI is a questionnaire used to assess the functional disability caused by low back pain. It consists of 10 questions, each rated on a scale of 0 (none) to 5 (extreme). The scores from the 10 questions are added up to obtain the raw score; the raw score is divided by the maximum possible score (50) and multiplied by 100 to obtain a percentage score, interpreted as follows: 0-20%: Minimal disability, 21-40%: Moderate disability, 41-60%: Severe disability, 61-80%: Crippling disability, and 81-100%: Bedridden or completely disabled.

  5. ODI Score at Month 6 Follow-Up

    Time frame: Month 6 Post-Operation

    The ODI is a questionnaire used to assess the functional disability caused by low back pain. It consists of 10 questions, each rated on a scale of 0 (none) to 5 (extreme). The scores from the 10 questions are added up to obtain the raw score; the raw score is divided by the maximum possible score (50) and multiplied by 100 to obtain a percentage score, interpreted as follows: 0-20%: Minimal disability, 21-40%: Moderate disability, 41-60%: Severe disability, 61-80%: Crippling disability, and 81-100%: Bedridden or completely disabled.

  6. ODI Score at Month 12 Follow-Up

    Time frame: Month 12 Post-Operation

    The ODI is a questionnaire used to assess the functional disability caused by low back pain. It consists of 10 questions, each rated on a scale of 0 (none) to 5 (extreme). The scores from the 10 questions are added up to obtain the raw score; the raw score is divided by the maximum possible score (50) and multiplied by 100 to obtain a percentage score, interpreted as follows: 0-20%: Minimal disability, 21-40%: Moderate disability, 41-60%: Severe disability, 61-80%: Crippling disability, and 81-100%: Bedridden or completely disabled.

  7. ODI Score at Month 24 Follow-Up

    Time frame: Month 24 Post-Operation

    The ODI is a questionnaire used to assess the functional disability caused by low back pain. It consists of 10 questions, each rated on a scale of 0 (none) to 5 (extreme). The scores from the 10 questions are added up to obtain the raw score; the raw score is divided by the maximum possible score (50) and multiplied by 100 to obtain a percentage score, interpreted as follows: 0-20%: Minimal disability, 21-40%: Moderate disability, 41-60%: Severe disability, 61-80%: Crippling disability, and 81-100%: Bedridden or completely disabled.

  8. Numeric Rating Scale (NRS) - Back Pain Score at Pre-Op Visit

    Time frame: Pre-Operation Visit (Day 0)

    Participants evaluate leg and back pain using a VAS ranging from 0 cm to 10 cm. Lower scores indicate lower levels of pain.

  9. NRS - Back Pain Score at Week 6 Follow-Up

    Time frame: Week 6 Post-Operation

    Participants evaluate leg and back pain using a VAS ranging from 0 cm to 10 cm. Lower scores indicate lower levels of pain.

  10. NRS - Back Pain Score at Month 3 Follow-Up

    Time frame: Month 3 Post-Operation

    Participants evaluate leg and back pain using a VAS ranging from 0 cm to 10 cm. Lower scores indicate lower levels of pain.

  11. NRS - Back Pain Score at Month 6 Follow-Up

    Time frame: Month 6 Post-Operation

    Participants evaluate leg and back pain using a VAS ranging from 0 cm to 10 cm. Lower scores indicate lower levels of pain.

  12. NRS - Back Pain Score at Month 12 Follow-Up

    Time frame: Month 12 Post-Operation

    Participants evaluate leg and back pain using a VAS ranging from 0 cm to 10 cm. Lower scores indicate lower levels of pain.

  13. NRS - Back Pain Score at Month 24 Follow-Up

    Time frame: Month 24 Post-Operation

    Participants evaluate leg and back pain using a VAS ranging from 0 cm to 10 cm. Lower scores indicate lower levels of pain.

  14. Short Form 12 (SF-12) - Physical Component Summary (PCS) Score at Pre-Op Visit

    Time frame: Pre-Operation Visit (Day 0)

    The SF-12 PCS is a physical component summary score from the Short Form 12 (SF-12) health survey. The PCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score. The final score ranges from 0-100 with a mean of 50. Higher scores indicate greater physical quality of life.

  15. SF-12 - PCS Score at Week 6 Follow-Up

    Time frame: Week 6 Post-Operation

    The SF-12 PCS is a physical component summary score from the Short Form 12 (SF-12) health survey. The PCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score. The final score ranges from 0-100 with a mean of 50. Higher scores indicate greater physical quality of life.

  16. SF-12 - PCS Score at Month 3 Follow-Up

    Time frame: Month 3 Post-Operation

    The SF-12 PCS is a physical component summary score from the Short Form 12 (SF-12) health survey. The PCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score. The final score ranges from 0-100 with a mean of 50. Higher scores indicate greater physical quality of life.

  17. SF-12 - PCS Score at Month 6 Follow-Up

    Time frame: Month 6 Post-Operation

    The SF-12 PCS is a physical component summary score from the Short Form 12 (SF-12) health survey. The PCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score. The final score ranges from 0-100 with a mean of 50. Higher scores indicate greater physical quality of life.

  18. SF-12 - PCS Score at Month 12 Follow-Up

    Time frame: Month 12 Post-Operation

    The SF-12 PCS is a physical component summary score from the Short Form 12 (SF-12) health survey. The PCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score. The final score ranges from 0-100 with a mean of 50. Higher scores indicate greater physical quality of life.

  19. SF-12 - PCS Score at Month 24 Follow-Up

    Time frame: Month 24 Post-Operation

    The SF-12 PCS is a physical component summary score from the Short Form 12 (SF-12) health survey. The PCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score. The final score ranges from 0-100 with a mean of 50. Higher scores indicate greater physical quality of life.

  20. SF-12 - Mental Component Summary (MCS) Score at Pre-Op Visit

    Time frame: Pre-Operation Visit (Day 0)

    The SF-12 MCS is a mental component summary score from the Short Form 12 (SF-12) health survey. The MCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score. The final score ranges from 0-100 with a mean of 50. Higher scores indicate greater mental quality of life.

  21. SF-12 - MCS Score at Week 6 Follow-Up

    Time frame: Week 6 Post-Operation

    The SF-12 MCS is a mental component summary score from the Short Form 12 (SF-12) health survey. The MCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score. The final score ranges from 0-100 with a mean of 50. Higher scores indicate greater mental quality of life.

  22. SF-12 - MCS Score at Month 3 Follow-Up

    Time frame: Month 3 Follow-Up Post-Operation

    The SF-12 MCS is a mental component summary score from the Short Form 12 (SF-12) health survey. The MCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score. The final score ranges from 0-100 with a mean of 50. Higher scores indicate greater mental quality of life.

  23. SF-12 - MCS Score at Month 6 Follow-Up

    Time frame: Month 6 Post-Operation

    The SF-12 MCS is a mental component summary score from the Short Form 12 (SF-12) health survey. The MCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score. The final score ranges from 0-100 with a mean of 50. Higher scores indicate greater mental quality of life.

  24. Euro-Qol 5-Dimension (EQ-5D) Score at Pre-Op Visit

    Time frame: Pre-Operation Visit (Day 0)

    5-item self-report questionnaire. Each item describes a different aspect of health: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Participants rank items on a 3-point Likert scale from 1-3: 1 = no problems; 2 = some problems; 3 = extreme problems. The total score is the sum of responses and ranges from 5-15; lower scores indicate better overall health.

  25. EQ-5D Score at Week 6 Follow-Up

    Time frame: Week 6 Post-Operation

    5-item self-report questionnaire. Each item describes a different aspect of health: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Participants rank items on a 3-point Likert scale from 1-3: 1 = no problems; 2 = some problems; 3 = extreme problems. The total score is the sum of responses and ranges from 5-15; lower scores indicate better overall health.

  26. EQ-5D Score at Month 3 Follow-Up

    Time frame: Month 3 Post-Operation

    5-item self-report questionnaire. Each item describes a different aspect of health: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Participants rank items on a 3-point Likert scale from 1-3: 1 = no problems; 2 = some problems; 3 = extreme problems. The total score is the sum of responses and ranges from 5-15; lower scores indicate better overall health.

  27. EQ-5D Score at Month 6 Follow-Up

    Time frame: Month 6 Post-Operation

    5-item self-report questionnaire. Each item describes a different aspect of health: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Participants rank items on a 3-point Likert scale from 1-3: 1 = no problems; 2 = some problems; 3 = extreme problems. The total score is the sum of responses and ranges from 5-15; lower scores indicate better overall health.

  28. EQ-5D Score at Month 12 Follow-Up

    Time frame: Month 12 Post-Operation

    5-item self-report questionnaire. Each item describes a different aspect of health: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Participants rank items on a 3-point Likert scale from 1-3: 1 = no problems; 2 = some problems; 3 = extreme problems. The total score is the sum of responses and ranges from 5-15; lower scores indicate better overall health.

  29. EQ-5D Score at Month 24 Follow-Up

    Time frame: Month 24 Post-Operation

    5-item self-report questionnaire. Each item describes a different aspect of health: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Participants rank items on a 3-point Likert scale from 1-3: 1 = no problems; 2 = some problems; 3 = extreme problems. The total score is the sum of responses and ranges from 5-15; lower scores indicate better overall health.

  30. Pain Catastrophizing Scale (PCS) Score at Pre-Op Visit

    Time frame: Pre-Operation Visit (Day 0)

    Self-report questionnaire containing 13 items that describe different thoughts and feelings that may be associated with pain. Participants rank each item on a Likert scale from 0 (not at all) to 4 (all the time). Scores range from 0 to 52; lower scores indicate lower levels of catastrophic thinking related to pain.

  31. PCS Score at Week 6 Follow-Up

    Time frame: Week 6 Post-Operation

    Self-report questionnaire containing 13 items that describe different thoughts and feelings that may be associated with pain. Participants rank each item on a Likert scale from 0 (not at all) to 4 (all the time). Scores range from 0 to 52; lower scores indicate lower levels of catastrophic thinking related to pain.

  32. PCS Score at Month 3 Follow-Up

    Time frame: Month 3 Post-Operation

    Self-report questionnaire containing 13 items that describe different thoughts and feelings that may be associated with pain. Participants rank each item on a Likert scale from 0 (not at all) to 4 (all the time). Scores range from 0 to 52; lower scores indicate lower levels of catastrophic thinking related to pain.

  33. PCS Score at Month 6 Follow-Up

    Time frame: Month 6 Post-Operation

    Self-report questionnaire containing 13 items that describe different thoughts and feelings that may be associated with pain. Participants rank each item on a Likert scale from 0 (not at all) to 4 (all the time). Scores range from 0 to 52; lower scores indicate lower levels of catastrophic thinking related to pain.

  34. PCS Score at Month 12 Follow-Up

    Time frame: Month 12 Post-Operation

    Self-report questionnaire containing 13 items that describe different thoughts and feelings that may be associated with pain. Participants rank each item on a Likert scale from 0 (not at all) to 4 (all the time). Scores range from 0 to 52; lower scores indicate lower levels of catastrophic thinking related to pain.

  35. PCS Score at Month 24 Follow-Up

    Time frame: Month 24 Post-Operation

    Self-report questionnaire containing 13 items that describe different thoughts and feelings that may be associated with pain. Participants rank each item on a Likert scale from 0 (not at all) to 4 (all the time). Scores range from 0 to 52; lower scores indicate lower levels of catastrophic thinking related to pain.

  36. Patient Reported Outcome Measure Information System (PROMIS) Item Bank v1.1 - Pain Interference Score at Pre-Op Visit

    Time frame: Pre-Operation Visit (Day 0)

    40-item self-report assessing the negative effects of pain on functioning in the range experienced by the vast majority of people who have pain. Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-160; lower scores indicate lower interference from pain. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate greater interference from pain.

  37. PROMIS Item Bank v1.1 - Pain Interference Score at Week 6 Follow-Up

    Time frame: Week 6 Post-Operation

    40-item self-report assessing the negative effects of pain on functioning in the range experienced by the vast majority of people who have pain. Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-160; lower scores indicate lower interference from pain. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate greater interference from pain.

  38. PROMIS Item Bank v1.1 - Pain Interference Score at Month 3 Follow-Up

    Time frame: Month 3 Post-Operation

    40-item self-report assessing the negative effects of pain on functioning in the range experienced by the vast majority of people who have pain. Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-160; lower scores indicate lower interference from pain. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate greater interference from pain.

  39. PROMIS Item Bank v1.1 - Pain Interference Score at Month 6 Follow-Up

    Time frame: Month 6 Post-Operation

    40-item self-report assessing the negative effects of pain on functioning in the range experienced by the vast majority of people who have pain. Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-160; lower scores indicate lower interference from pain. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate greater interference from pain.

  40. PROMIS Item Bank v1.1 - Pain Interference Score at Month 12 Follow-Up

    Time frame: Month 12 Post-Operation

    40-item self-report assessing the negative effects of pain on functioning in the range experienced by the vast majority of people who have pain. Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-160; lower scores indicate lower interference from pain. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate greater interference from pain.

  41. PROMIS Item Bank v1.1 - Pain Interference Score at Month 24 Follow-Up

    Time frame: Month 24 Post-Operation

    40-item self-report assessing the negative effects of pain on functioning in the range experienced by the vast majority of people who have pain. Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-160; lower scores indicate lower interference from pain. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate greater interference from pain.

  42. PROMIS Scale v1.0 - Pain Intensity 3a Score at Pre-Op Visit

    Time frame: Pre-Operation Visit (Day 0)

    3-item self-report assessment of how much a participant hurts. Participants rank items on a 5-point Likert scale ranging from 0 (Had no pain) to 4 (Very severe). The raw score is the sum of responses and ranges from 0-12; lower scores indicate lower levels of pain. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate higher intensity of pain.

  43. PROMIS Scale v1.0 - Pain Intensity 3a Score at Week 6 Follow-Up

    Time frame: Week 6 Post-Operation

    3-item self-report assessment of how much a participant hurts. Participants rank items on a 5-point Likert scale ranging from 0 (Had no pain) to 4 (Very severe). The raw score is the sum of responses and ranges from 0-12; lower scores indicate lower levels of pain. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate higher intensity of pain.

  44. PROMIS Scale v1.0 - Pain Intensity 3a Score at Month 3 Follow-Up

    Time frame: Month 3 Post-Operation

    3-item self-report assessment of how much a participant hurts. Participants rank items on a 5-point Likert scale ranging from 0 (Had no pain) to 4 (Very severe). The raw score is the sum of responses and ranges from 0-12; lower scores indicate lower levels of pain. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate higher intensity of pain.

  45. PROMIS Scale v1.0 - Pain Intensity 3a Score at Month 6 Follow-Up

    Time frame: Month 6 Post-Operation

    3-item self-report assessment of how much a participant hurts. Participants rank items on a 5-point Likert scale ranging from 0 (Had no pain) to 4 (Very severe). The raw score is the sum of responses and ranges from 0-12; lower scores indicate lower levels of pain. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate higher intensity of pain.

  46. PROMIS Scale v1.0 - Pain Intensity 3a Score at Month 12 Follow-Up

    Time frame: Month 12 Post-Operation

    3-item self-report assessment of how much a participant hurts. Participants rank items on a 5-point Likert scale ranging from 0 (Had no pain) to 4 (Very severe). The raw score is the sum of responses and ranges from 0-12; lower scores indicate lower levels of pain. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate higher intensity of pain.

  47. PROMIS Scale v1.0 - Pain Intensity 3a Score at Month 24 Follow-Up

    Time frame: Month 24 Post-Operation

    3-item self-report assessment of how much a participant hurts. Participants rank items on a 5-point Likert scale ranging from 0 (Had no pain) to 4 (Very severe). The raw score is the sum of responses and ranges from 0-12; lower scores indicate lower levels of pain. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate higher intensity of pain.

  48. PROMIS Bank v1.2 - Physical Function Score at Pre-Op Visit

    Time frame: Pre-Operation Visit (Day 0)

    120-item self-report assessment of physical health, physical function, pain, and fatigue. Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-480; lower scores indicate higher levels of physical function. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10. Higher scores indicate greater physical function.

  49. PROMIS Bank v1.2 - Physical Function Score at Week 6 Follow-Up

    Time frame: Week 6 Post-Operation

    120-item self-report assessment of physical health, physical function, pain, and fatigue. Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-480; lower scores indicate higher levels of physical function. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10. Higher scores indicate greater physical function.

  50. PROMIS Bank v1.2 - Physical Function Score at Month 3 Follow-Up

    Time frame: Month 3 Post-Operation

    120-item self-report assessment of physical health, physical function, pain, and fatigue. Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-480; lower scores indicate higher levels of physical function. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10. Higher scores indicate greater physical function.

  51. PROMIS Bank v1.2 - Physical Function Score at Month 6 Follow-Up

    Time frame: Month 6 Post-Operation

    120-item self-report assessment of physical health, physical function, pain, and fatigue. Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-480; lower scores indicate higher levels of physical function. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10. Higher scores indicate greater physical function.

  52. PROMIS Bank v1.2 - Physical Function Score at Month 12 Follow-Up

    Time frame: Month 12 Post-Operation

    120-item self-report assessment of physical health, physical function, pain, and fatigue. Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-480; lower scores indicate higher levels of physical function. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10. Higher scores indicate greater physical function.

  53. PROMIS Bank v1.2 - Physical Function Score at Month 24 Follow-Up

    Time frame: Month 24 Post-Operation

    120-item self-report assessment of physical health, physical function, pain, and fatigue. Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-480; lower scores indicate higher levels of physical function. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10. Higher scores indicate greater physical function.

  54. PROMIS Bank v2.0 - Mobility Score at Pre-Op Visit

    Time frame: Pre-Operation Visit (Day 0)

    15-item self-report assessment of activities of physical mobility. Each item is ranked on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-60; lower scores indicate higher levels of physical mobility. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate greater physical mobility.

  55. PROMIS Bank v2.0 - Mobility Score at Week 6 Follow-Up

    Time frame: Week 6 Post-Operation

    15-item self-report assessment of activities of physical mobility. Each item is ranked on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-60; lower scores indicate higher levels of physical mobility. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate greater physical mobility.

  56. PROMIS Bank v2.0 - Mobility Score at Month 3 Follow-Up

    Time frame: Month 3 Post-Operation

    15-item self-report assessment of activities of physical mobility. Each item is ranked on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-60; lower scores indicate higher levels of physical mobility. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate greater physical mobility.

  57. PROMIS Bank v2.0 - Mobility Score at Month 6 Follow-Up

    Time frame: Month 6 Post-Operation

    15-item self-report assessment of activities of physical mobility. Each item is ranked on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-60; lower scores indicate higher levels of physical mobility. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate greater physical mobility.

  58. PROMIS Bank v2.0 - Mobility Score at Month 12 Follow-Up

    Time frame: Month 12 Post-Operation

    15-item self-report assessment of activities of physical mobility. Each item is ranked on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-60; lower scores indicate higher levels of physical mobility. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate greater physical mobility.

  59. PROMIS Bank v2.0 - Mobility Score at Month 24 Follow-Up

    Time frame: Month 24 Post-Operation

    15-item self-report assessment of activities of physical mobility. Each item is ranked on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-60; lower scores indicate higher levels of physical mobility. The raw score is translated to give a T-score for each participant. The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10. Higher T-scores indicate greater physical mobility.

  60. Length of Operation

    Time frame: Intraoperative Period (Day 0) (typically between 2-7 hours)

  61. Length of Hospital Stay

    Time frame: From admission up to discharge (Up to Year 2 Post-Operation)

  62. Blood Loss During Procedure

    Time frame: Intraoperative Period (Day 0) (typically between 2-7 hours)

  63. Number of Participants Using Non-Prescription, Over-the-Counter (OTC) Drugs at Pre-Op Visit

    Time frame: Pre-Operation Visit (Day 0)

    Number of participants taking OTC drugs for pain relief.

  64. Number of Participants Using Non-Prescription, OTC Drugs at Week 6 Follow-Up

    Time frame: Week 6 Post-Operation

    Number of participants taking OTC drugs for pain relief.

  65. Number of Participants Using Non-Prescription, OTC Drugs at Month 3 Follow-Up

    Time frame: Month 3 Post-Operation

    Number of participants taking OTC drugs for pain relief.

  66. Number of Participants Using Non-Prescription, OTC Drugs at Month 6 Follow-Up

    Time frame: Month 6 Post-Operation

    Number of participants taking OTC drugs for pain relief.

  67. Number of Participants Using Non-Prescription, OTC Drugs at Month 12 Follow-Up

    Time frame: Month 12 Post-Operation

    Number of participants taking OTC drugs for pain relief.

  68. Number of Participants Using Non-Prescription, OTC Drugs at Month 24 Follow-Up

    Time frame: Month 24 Post-Operation

    Number of participants taking OTC drugs for pain relief.

  69. Number of Participants With Surgical Complications During Operation

    Time frame: Intraoperative Period (Day 0) (typically between 2-7 hours)

  70. Number of Participants With Surgical Complications at Week 6 Follow-Up

    Time frame: Week 6 Post-Operation

  71. Number of Participants With Surgical Complications at Month 3 Follow-Up

    Time frame: Month 3 Post-Operation

  72. Number of Participants With Surgical Complications at Month 6 Follow-Up

    Time frame: Month 6 Post-Operation

  73. Number of Participants With Surgical Complications at Month 12 Follow-Up

    Time frame: Month 12 Post-Operation

  74. Number of Participants With Surgical Complications at Month 24 Follow-Up

    Time frame: Month 24 Post-Operation

  75. SF-12 - MCS Score at Month 12 Follow-Up

    Time frame: Month 12 Post-Operation

    The SF-12 MCS is a mental component summary score from the Short Form 12 (SF-12) health survey. The MCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score. The final score ranges from 0-100 with a mean of 50. Higher scores indicate greater mental quality of life.

  76. SF-12 - MCS Score at Month 24 Follow-Up

    Time frame: Month 12 Post-Operation

    The SF-12 MCS is a mental component summary score from the Short Form 12 (SF-12) health survey. The MCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score. The final score ranges from 0-100 with a mean of 50. Higher scores indicate greater mental quality of life.

Sponsors and collaborators

Lead sponsor

NYU Langone Health

Other

Registry information

Official study title

Prospective, Blinded, Non-randomized Study of Thoracolumbar Spinal Fusion Graft Efficacy: Bone Marrow Aspirate Concentrate and Allograft Versus Recombinant Bone Morphogenetic Protein-2 (BMP)

Important dates

Study start
2018
Primary completion
2024
Study completion
2024
First posted
Oct 5, 2016
Registry last updated
Jul 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.